Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature

Thrombopoietin receptor agonists (TPO-RA) are currently indicated for the treatment of chronic immune thrombocytopenia and relapsed refractory aplastic anemia. However, the off-label use of these drugs is more and more frequent, including in the setting of aplasia secondary to chemotherapy and hemop...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortolotti, Marta, Pettine, Loredana, Zaninoni, Anna, Croci, Giorgio Alberto, Barcellini, Wilma, Fattizzo, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032708/
https://www.ncbi.nlm.nih.gov/pubmed/35455416
http://dx.doi.org/10.3390/ph15040419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032708/
https://www.ncbi.nlm.nih.gov/pubmed/35455416
http://dx.doi.org/10.3390/ph15040419

Ejemplares similares